Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Large-scale testing (Phase 3)Active Not RecruitingNCT06396065
What this trial is testing

Phase III Study of AK112 for NSCLC Patients

Who this might be right for
Non-Squamous Non-small Cell Lung Cancer
Summit Therapeutics 420
Large-scale testing (Phase 3)Ended earlyNCT00630565
What this trial is testing

Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Early research (Phase 1)Active Not RecruitingNCT05236036
What this trial is testing

Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

Who this might be right for
AstrocytomaGlioblastomaGlioblastoma, IDH-Wildtype+2 more
Northwestern University 86
Early research (Phase 1)Study completedNCT02199171
What this trial is testing

Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer

Who this might be right for
FIGO Stage IIC-IV Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma
University of California, Irvine 30
Early research (Phase 1)Active Not RecruitingNCT02159495
What this trial is testing

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00060944
What this trial is testing

Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Who this might be right for
LiposarcomaLeiomyosarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 271
Testing effectiveness (Phase 2)Study completedNCT01533181
What this trial is testing

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Recurrent Small Cell Lung Carcinoma
National Cancer Institute (NCI) 44
Testing effectiveness (Phase 2)Study completedNCT00003957
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Fox Chase Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableStudy completedNCT01563211
What this trial is testing

Predictive Model of Therapy Outcomes in Breast Cancer Patients

Who this might be right for
Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Imperial College London 70
Not applicableUnknownNCT00278239
What this trial is testing

Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Children+1 more
Children's Cancer and Leukaemia Group
Testing effectiveness (Phase 2)Study completedNCT01251575
What this trial is testing

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more
Fred Hutchinson Cancer Center 77
Testing effectiveness (Phase 2)Study completedNCT01020734
What this trial is testing

Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Leukemia
Asan Medical Center 263
Testing effectiveness (Phase 2)Ended earlyNCT04379518
What this trial is testing

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
Roswell Park Cancer Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT00003223
What this trial is testing

SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 5
Testing effectiveness (Phase 2)Study completedNCT00462488
What this trial is testing

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

Who this might be right for
Urinary Bladder CancerBladder CancerBladder Neoplasms+1 more
Sesen Bio, Inc. 46
Early research (Phase 1)Study completedNCT02222688
What this trial is testing

UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Thomas Kipps 26
Large-scale testing (Phase 3)Active Not RecruitingNCT01993810
What this trial is testing

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Who this might be right for
Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7+3 more
Radiation Therapy Oncology Group 330
Next Page